{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T08:33:51Z","timestamp":1718440431362},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/coc.0b013e31827e5505","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:30:15Z","timestamp":1361471415000},"page":"535-538","source":"Crossref","is-referenced-by-count":5,"title":["Radiotherapy Alone or Combined With Chemotherapy for the Treatment of Squamous Cell Carcinoma of the Base of the Tongue"],"prefix":"10.1097","volume":"37","author":[{"given":"Brian J.","family":"Gebhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"McAfee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hed.20012","article-title":". Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.","volume":"26","author":"Malone","year":"2004","journal-title":"Head Neck"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hed.21261","article-title":". Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma.","volume":"32","author":"Mendenhall","year":"2010","journal-title":"Head Neck"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005537-200303000-00028","article-title":". Altered fractionation andor adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.","volume":"113","author":"Mendenhall","year":"2003","journal-title":"Laryngoscope"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":". A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(97)00079-0","article-title":". Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.","volume":"44","author":"Horiot","year":"1997","journal-title":"Radiother Oncol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hed.20522","article-title":". Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.","volume":"29","author":"Cmelak","year":"2007","journal-title":"Head Neck"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.oraloncology.2009.01.014","article-title":". Clinical outcome of oropharyngeal carcinoma treated with platinum-based chemoradiotherapy.","volume":"45","author":"Nakamura","year":"2009","journal-title":"Oral Oncol"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hed.20694","article-title":". Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base.","volume":"30","author":"Lawson","year":"2008","journal-title":"Head Neck"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hed.20947","article-title":". Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.","volume":"31","author":"Finnegan","year":"2009","journal-title":"Head Neck"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R13-3-20210128","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration.","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0360-3016(98)00059-5","article-title":". Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone.","volume":"41","author":"Nisi","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hed.1092","article-title":"Surgical treatment of squamous cell carcinoma of the base of tongue.","volume":"23","author":"Gourin","year":"2001","journal-title":"Head Neck"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/(SICI)1097-0347(199812)20:8<668::AID-HED2>3.0.CO;2-9","article-title":". Long term results of primary radiotherapy withwithout neck dissection for squamous cell cancer of the base of tongue.","volume":"20","author":"Harrison","year":"1998","journal-title":"Head Neck"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0360-3016(95)00088-G","article-title":". Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.","volume":"33","author":"Mak","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0360-3016(03)00597-2","article-title":". Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.","volume":"57","author":"Gibbs","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.coc.0000189680.60262.eb","article-title":". Definitive radiotherapy for squamous cell carcinoma of the base of tongue.","volume":"29","author":"Mendenhall","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":". Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hed.21360","article-title":". Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.","volume":"32","author":"Pederson","year":"2010","journal-title":"Head Neck"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hed.21634","article-title":". Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.","volume":"33","author":"Dragovic","year":"2011","journal-title":"Head Neck"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":". Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":". Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"R25-3-20210128","first-page":"9","article-title":"Seduction by induction J Clin Oncol.","volume":"27","author":"Beitler","year":"2009","journal-title":""},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":". Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1002\/cncr.25189","article-title":". Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer.","volume":"116","author":"Newlin","year":"2010","journal-title":"Cancer"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1200\/JCO.2006.06.1291","article-title":"Clinical implications of human papillomavirus in head and neck cancers.","volume":"24","author":"Fakhry","year":"2006","journal-title":"J Clin Oncol"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1002\/ijc.24994","article-title":". The role of human papillomavirus in the increased incidence of base of tongue cancer.","volume":"126","author":"Attner","year":"2010","journal-title":"Int J Cancer"},{"key":"R30-3-20210128","first-page":"1467","article-title":". Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.","volume":"29","author":"Jo","year":"2009","journal-title":"Anticancer Res"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":". Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e31827e5505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:50:27Z","timestamp":1714989027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201412000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31827e5505","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}